These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 17976201)

  • 61. Insulin glargine and glulisine SoloSTAR pens for the treatment of diabetes.
    Garg S; Kelly WC; Garg S
    Expert Rev Med Devices; 2008 Mar; 5(2):113-23. PubMed ID: 18331174
    [TBL] [Abstract][Full Text] [Related]  

  • 62. 2008 resource guide. Insulin. Along with human insulin analogs, recombinant DNA human insulins are the most widely used insulins in this country. Through genetic engineering, bacteria or yeast are transformed into little "factories" that produce synthetic human insulin.
    Diabetes Forecast; 2008 Jan; 61(1):RG11-4. PubMed ID: 18290288
    [No Abstract]   [Full Text] [Related]  

  • 63. [Skin complications of diabetes mellitus therapy].
    Olsovský J
    Vnitr Lek; 2006 May; 52(5):474-6. PubMed ID: 16771093
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Lipoatrophy at insulin injection site.
    Velayutham P; Shriraam M; Bhadada S; Bhansali A
    J Assoc Physicians India; 2008 May; 56():335. PubMed ID: 18700641
    [No Abstract]   [Full Text] [Related]  

  • 65. Hypoglycemia in type 1 diabetes: a still unresolved problem in the era of insulin analogs and pump therapy.
    Shalitin S; Phillip M
    Diabetes Care; 2008 Feb; 31 Suppl 2():S121-4. PubMed ID: 18227471
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Suggested insulin regimens for patients with type 1 diabetes mellitus who wish to fast during the month of Ramadan.
    Kobeissy A; Zantout MS; Azar ST
    Clin Ther; 2008 Aug; 30(8):1408-15. PubMed ID: 18803984
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: Chinese PRESENT study.
    Gao Y; Guo XH; Vaz JA;
    Diabetes Obes Metab; 2009 Jan; 11(1):33-40. PubMed ID: 18494806
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Soft tumors in the mid abdomen and thighs. Diabetes, lipohypertrophy].
    Winter M
    MMW Fortschr Med; 2011 Oct; 153(43):5. PubMed ID: 22097618
    [No Abstract]   [Full Text] [Related]  

  • 69. [Biosynthetic insulin. A treatment method in diabetic lipoatrophy].
    Hansen LB; Permin H; Asfeldt V
    Ugeskr Laeger; 1988 May; 150(21):1292-4. PubMed ID: 3289218
    [No Abstract]   [Full Text] [Related]  

  • 70. Insulin analogues: an example of applied medical science.
    Sheldon B; Russell-Jones D; Wright J
    Diabetes Obes Metab; 2009 Jan; 11(1):5-19. PubMed ID: 19120431
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Lipodystrophy appearing during treatment with monocomponent insulin].
    De Mattia G; Fini M; Ventura C; Tullo MG; Laurenti O; Spada R; Marinoni G
    Clin Ter; 1984 Oct; 111(2):169-70. PubMed ID: 6239740
    [No Abstract]   [Full Text] [Related]  

  • 72. Biphasic insulin aspart 30 three times daily is more effective than a twice-daily regimen, without increasing hypoglycemia, in Chinese subjects with type 2 diabetes inadequately controlled on oral antidiabetes drugs.
    Yang W; Ji Q; Zhu D; Yang J; Chen L; Liu Z; Yu D; Yan L
    Diabetes Care; 2008 May; 31(5):852-6. PubMed ID: 18268073
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A new case of lipoatrophy with lispro insulin in insulin pump therapy: is there any insulin preparation free of complications?
    Ampudia-Blasco FJ; Hasbum B; Carmena R
    Diabetes Care; 2003 Mar; 26(3):953-4. PubMed ID: 12610070
    [No Abstract]   [Full Text] [Related]  

  • 74. Cost-effectiveness of switching to biphasic insulin aspart in poorly-controlled type 2 diabetes patients in China.
    Palmer JL; Gibbs M; Scheijbeler HW; Kotchie RW; Nielsen S; White J; Valentine WJ
    Adv Ther; 2008 Aug; 25(8):752-74. PubMed ID: 18704282
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A case of insulin lipohypertrophy in a young diabetic female successfully treated by vibroliposuction.
    Gandolfi E; Thione A
    J Plast Reconstr Aesthet Surg; 2009 Dec; 62(12):e601-3. PubMed ID: 19250895
    [No Abstract]   [Full Text] [Related]  

  • 76. [Postinjection insulin lipodystrophy].
    Pisarskaia IV; Khaiĭkina MB
    Med Sestra; 1981 Jul; 40(7):54-5. PubMed ID: 7022088
    [No Abstract]   [Full Text] [Related]  

  • 77. Re: Insulin therapy in type 2 diabetes patients failing oral agents: cost-effectiveness of biphasic insulin aspart 70/30 vs. insulin glargine in the US.
    Currie CJ; Evans M; Poole CD
    Diabetes Obes Metab; 2008 Jan; 10(1):94-5. PubMed ID: 18095951
    [No Abstract]   [Full Text] [Related]  

  • 78. Differential lipid profile and hormonal response in type 2 diabetes by exogenous insulin aspart versus the insulin secretagogue repaglinide, at the same glycemic control.
    Chisalita SI; Lindström T; Eson Jennersjö P; Paulsson JF; Westermark GT; Olsson AG; Arnqvist HJ
    Acta Diabetol; 2009 Mar; 46(1):35-42. PubMed ID: 18777156
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: experience from the PRESENT study.
    Khutsoane D; Sharma SK; Almustafa M; Jang HC; Azar ST; Danciulescu R; Shestakova M; Ayad NM; Guler S; Bech OM;
    Diabetes Obes Metab; 2008 Mar; 10(3):212-22. PubMed ID: 18269636
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The management of lipohypertrophy in diabetes care.
    Hambridge K
    Br J Nurs; 2007 May 10-23; 16(9):520-4. PubMed ID: 17551441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.